Affymax, (FRA:A5Y) Scaled Net Operating Assets : 0.28 (As of Jun. 2014)

View and export this data going back to . Start your Free Trial

What is Affymax, Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Affymax,'s operating assets for the quarter that ended in Jun. 2014 was €1.46 Mil. Affymax,'s operating liabilities for the quarter that ended in Jun. 2014 was €0.16 Mil. Affymax,'s Total Assets for the quarter that ended in Mar. 2014 was €4.67 Mil. Therefore, Affymax,'s scaled net operating assets (SNOA) for the quarter that ended in Jun. 2014 was 0.28.

Affymax, Scaled Net Operating Assets Historical Data

The historical data trend for Affymax,'s Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, Scaled Net Operating Assets Chart

Affymax, Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.47

-0.13

-0.17

-0.51

-0.06

Affymax, Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.15	-0.36	-0.44	-0.96	0.28

Competitive Comparison of Affymax,'s Scaled Net Operating Assets

For the Biotechnology subindustry, Affymax,'s Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affymax,'s Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax,'s Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Affymax,'s Scaled Net Operating Assets falls into.

Affymax, Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Affymax,'s Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2013 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2013 )
=	(Operating Assets (A: Dec. 2013 )	-	Operating Liabilities (A: Dec. 2013 ))	/	Total Assets (A: Dec. 2012 )
=	(1.347	-	6.476)	/	90.081
=	-0.06

where

	Operating Assets		(A: Dec. 2013 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5.433	-	4.086
=	1.347

	Operating Liabilities		(A: Dec. 2013 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6.476	-	0	-	0
=	6.476

Affymax,'s Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2014 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2014 )
=	(Operating Assets (Q: Jun. 2014 )	-	Operating Liabilities (Q: Jun. 2014 ))	/	Total Assets (Q: Mar. 2014 )
=	(1.461	-	0.158)	/	4.673
=	0.28

where

	Operating Assets		(Q: Jun. 2014 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.963	-	2.502
=	1.461

	Operating Liabilities		(Q: Jun. 2014 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.158	-	0	-	0
=	0.158

Affymax, Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Affymax,'s Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Affymax, (FRA:A5Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020

Website

http://www.affymax.com

Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines